{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By KATIE THOMAS", "person": [{"rank": 1, "role": "reported", "firstname": "Katie", "organization": "", "lastname": "THOMAS"}]}, "abstract": "Some critics say drug maker Shire is going too far in its marketing of Vyvanse, amphetamine-based drug that was recently approved to treat binge-eating disorder; Shire spent years before approval shaping public perception and diagnosis of binge-eating disorder, much as it did with ADHD in the past; controversy highlights marketing strategy that has yielded billions in profits and that many say presents public danger.", "type_of_material": "News", "word_count": "1347", "lead_paragraph": "The strategy for a new drug to treat binge-eating disorder reveals how a pharmaceutical company can influence the treatment of a medical condition.", "pub_date": "2015-02-25T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Shire, Maker of Binge-Eating Drug Vyvanse, First Marketed the Disease", "print_headline": "Maker of a Drug to Treat Binge-Eating Marketed the Disease First"}, "snippet": "The strategy for a new drug to treat binge-eating disorder reveals how a pharmaceutical company can influence the treatment of a medical condition.", "multimedia": [{"height": 126, "url": "images/2015/02/25/business/25BINGE1/25BINGE1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/02/25/business/25BINGE1/25BINGE1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/02/25/business/25BINGE1/25BINGE1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/02/25/business/25BINGE1/25BINGE1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/02/25/business/25BINGE1/25BINGE1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/02/25/business/25BINGE1/25BINGE1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/02/25/business/shire-maker-of-binge-eating-drug-vyvanse-first-marketed-the-disease.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Shire PLC", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Eating Disorders", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Advertising and Marketing", "name": "subject"}, {"rank": "5", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}], "blog": [], "_id": "54ecb2d638f0d828b27a0fa3", "source": "The New York Times"}